Latest CellPort Technologies Stories
EXTON, Pa., Oct. 17, 2012 /PRNewswire/ -- Absorption Systems, a world leader in developing novel test systems for pharmacokinetics and drug-drug interactions, announces the launch of ExpressPlus(TM) Transporters, a series of early-stage screening assays to detect interactions of new drug candidates with membrane proteins called transporters. ExpressPlus is a natural extension of Absorption Systems' proprietary cell-based test systems, CellPort Technologies®. The new drug...
EXTON, Pa., July 27, 2012 /PRNewswire/ -- Absorption Systems, a world leader in developing novel test systems for drug transporters, announces the availability of a long-awaited assay platform for the human BCRP transporter, also known as breast cancer resistance protein. Cell biologists at the company have successfully over-expressed BCRP in a stable manner in the MDCK cell line, thereby creating BCRP-MDCK cells, the latest addition to its CellPort Technologies® product line. The...
FDA-funded Technology May Contribute to Improved Drug Safety by Predicting Drug Interactions Involving Transporters Exton, PA (PRWEB) March 06, 2012 Absorption Systems, a world leader in drug transporters, announces the issuance of the third U.S. patent protecting intellectual property around its CellPort Technologies® portfolio of in vitro test systems. The new patent, number 8,110,398, covers its MRP2 knockdown cell line and extends the patent coverage on the company’s...
Expanded patent protection for unique FDA-funded technology, which helps predict the risk of drug interactions involving transporters. Exton, PA (PRWEB) February 21, 2012 Absorption Systems, a world leader in drug transporters, announces that a new U.S. patent issued on January 31st, protecting intellectual property around its P-glycoprotein (P-gp) knockdown cell line within the company’s CellPort Technologies® brand. The new patent, number 8,105,828, extends the patent coverage...
Unique Technology Enables Early Prediction of Drug-Drug Interactions Involving Transporters Exton, PA (PRWEB) November 02, 2011 Absorption Systems, a leader in testing drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), today announced that patents have issued in Europe (no. 2084529) and Panama (no. 87554-01) covering its novel Breast Cancer Resistance Protein (BCRP) knockdown cell line within the company’s CellPort Technologies® brand. These...
Absorption Systems, a leading preclinical ADMET contract research organization for drugs and medical devices, was named a finalist for the "Emerging Life Sciences Company of the Year" for the 18th Annual Enterprise Awards in recognition of their CellPort Technologies testing platform.Exton, PA (PRWEB) April 21, 2011 Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today announced that the company has been...
